Webinar – How real world evidence complements clinical trial data

Fourth ParadigMS Symposium -How real world evidence complements clinical trial data

14th of March 2019, Fourth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised an interactive learning and networking experience. Here you can review one of the two lectures that were on the agenda.

ABSTRACT
Prof Ralf Ziemssen gave an introduction and his perspective on real world data in MS. What is it and why is it so important to collect them. And how real world evidence complements clinical trial data.

TJALF ZIEMSSEN
Professor Tjalf Ziemssen is Director of the Center of Clinical Neuroscience with its Multiple Sclerosis Centre (MSC), neuroimmunological lab (NIL) and
autonomic lab (ANF) at the Carl Gustav Carus University Hospital, in Dresden, Germany. 
He is an active member of several neurological societies, including the German Neurological Society, the European Neurological Society, the
American Academy of Neurology and the European Federation of Autonomic Societies.


Media

Details

  • Directors

    ParadigMS
  • Author(s)

    Prof. Tjalf Ziemssen
  • Country

    Belgium
  • Release Date

    March 14, 2019
  • Views


You Might Also Like

Webinar – The Neuroimmunology of MS: Basics of Immunology and MoA of DMT’s (Part II)

Webinar – The Neuroimmunology of MS: Basics of Immunology and MoA of DMT’s (Part I)

Webinar – Pregnancy in MS

Webinar – MRI in MS


Subscribe to our bi-annual Newsletter

ParadigMS does not send eNewsletters that contain advertisements and we do not share your contact details with sponsors (unless we received your explicit consent)